2017 Seminar upon Program “Thymidine Kinase (TK1) application in early tumor risk assessment in muti-healthcare center”held in Sanya.
Position: Home  /  News  /  Company News
2017 Seminar upon Program “Thymidine Kinase (TK1) application in early tumor risk assessment in muti-healthcare center”held in Sanya.
2017 Seminar upon Program “Thymidine Kinase (TK1) application in early tumor risk assessment in muti-healthcare center”held in Sanya.

Time:2017-03-03


    2017 Seminar upon Program “Thymidine Kinase (TK1) application in early tumor risk assessment in muti-healthcare center”held in Sanya, Hainan.

    On 17-18th, February , during nice and wonderful days in Sanya Hainan, sponsored by  China Health Promotion Foundation,  the Seminar upon Program “Thymidine Kinase (TK1) application in early tumor risk assessment in muti-healthcare center” Was held by SSTKbio.

    Decades of specialists, experts, and scholars from health management sector all over the nation attended the seminar, The Chairman of China Health Promotion Foundation, Professor Shuzhong Bai, the Directors of China Health Promotion Foundation, Professor Qiang Zeng and Gang Chen presided the seminar.

     There was a warm and deep discussion regarding the application of TK1 in different hospitals and regions, and very active and inspiring atmosphere.




  With the two days discussion and exchange,, all the participants gained a deep understanding of the Application TK1, and everyone hold great confidence to promote  the program.

Back